Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration.

Sherrie L AspinallXinhua ZhaoMark C GeraciChester B GoodFrancesca E CunninghamBernadette B HeronDaniel BeckerSteve LeeVinay Prasadnull null

Published in: Cancer medicine (2019)

Our analysis of targeted therapies for advanced RCC in VHA suggests duration of treatment is shorter in a real-world setting than in clinical trials, and dose reductions and ADEs are more common.

Keyphrases

renal cell carcinoma
clinical trial
healthcare
public health
mental health
randomized controlled trial
health information
health promotion
human health